Endothelium-derived factors modulate tone and may be involved in hyporeacti
vity to vasoconstrictors, such as norepinephrine or angiotensin II, as has
been previously described during gestation. The endothelium produces endoth
elin-1, a major vasoconstrictor peptide, therefore aortic contractions to e
ndothelin-1 (10(-10) to 3 x 10(-7) M) were used to assess the role of the e
ndothelium in pregnant Wistar rats (at 20 days of gestation). Late pregnanc
y is characterized by a significantly diminished systolic blood pressure in
conscious rats (-17 mmHg, P < 0.001, n = 14). In pregnant and in age-match
ed nonpregnant female rats, endothelin-1 induced aortic contraction was gre
ater when endothelium was present (at least P < 0.01). Indomethacin signifi
cantly reduced this contraction in aortic rings with intact endothelium in
all groups. In aortic rings that had endothelium physically removed, contra
ction to endothelin-1 was greater in pregnant rats than in nonpregnant ones
. Indomethacin decreased contraction of aortic rings in pregnant rats only.
These results suggest an enhanced synthesis of vasoconstrictors by cycloox
ygenases in vascular smooth muscle during pregnancy. In vessels with intact
endothelium, we did not find hyporeactivity to endothelin-1 during late pr
egnancy. Contraction to endothelin-1 involved ETA receptors because it was
decreased by BQ-123, an ETA receptor antagonist, whereas there was no signi
ficant change when using BQ-788, an ETB receptor antagonist.